Enter assignee name

EPO Patents = 5

Trademarks = 3

Forward Citations = 114

Loading Chart...

3 inventors (with patents filed for the assignee):

John S Petersen (15 out of 40 patents)

James Shanahan (11 out of 11 patents)

Peter Cornelius (4 out of 8 patents)

19 patents: Sort by Forward Citations

1. 12419846 - Biomarkers of METAP2 inhibitors and applications thereof (2025-09-23),

2. 11612577 - Biomarkers of METAP2 inhibitors and applications thereof (2023-03-28),

3. 11304944 - MetAP2 inhibitors and methods of treating obesity (2022-04-19),

4. 11273142 - Treatment for tumors driven by metabolic dysfunction (2022-03-15),

5. 10722532 - Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof (2020-07-28),

6. 10646463 - Treatment for tumors driven by metabolic dysfunction (2020-05-12),

7. 10588904 - METAP2 inhibitors and methods of treating obesity (2020-03-17),

8. 10287277 - Fumagillol derivatives and polymorphs thereof (2019-05-14),

9. 10159692 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2018-12-25),

10. 10010544 - METAP2 inhibitors and methods of treating obesity (2018-07-03),

11. 9969722 - Fumagillol derivatives and polymorphs thereof (2018-05-15),

12. 9895449 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2018-02-20),

13. 9757373 - MetAP2 inhibitors and methods of treating obesity (2017-09-12),

14. 9750737 - METAP2 inhibitors and methods of treating obesity (2017-09-05),

15. 9730955 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2017-08-15),

SynDevRx, Inc. is a pharmaceutical company focused on the development of innovative cancer therapies. Leveraging cutting-edge research and state-of-the-art technology, SynDevRx aims to deliver targeted and personalized treatment options for patients. With a strong commitment to improving patient outcomes, the company collaborates with leading scientists and medical professionals to advance the field of oncology. SynDevRx is dedicated to revolutionizing cancer care through its novel drug discovery and development programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#121 in Cambridge, MA

#1,008 in Massachusetts

#16,629 in US

#31,713 in the World

Cambridge, MA, United States of America

Syndevrx, Inc.

Forward Citations = 114

3 inventors:

John S Petersen (15 out of 40 patents)

James Shanahan (11 out of 11 patents)

Peter Cornelius (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com